Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (101-110 of 315) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|October 4, 2007
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysisCatherine J Wu, Mark Gladwin, John Tisdale, et al.
The New England Journal of Medicine|April 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host DiseaseKaramjeet S Sandhu, Jessica Cheng, Patrick W Mellors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Leukemia & Lymphoma|March 5, 2003
Quantitative monitoring of BCR/ABL transcript during STI-571 therapyCatherine J Wu, Donna Neuberg, Antoinette Chillemi, et al.
Transfusion|February 14, 2004
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapyAbba C Zubair, David Zahrieh, Heather Daley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopesYishai Ofran, Haesook T Kim, Vladimir Brusic, et al.
Respiratory Medicine|December 1, 2012
Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantationLee Gazourian, Anna Maria F Coronata, Angela J Rogers, et al.
Journal of Oncology Practice|January 2, 2013
Development and implementation of a computerized system for collection, processing, and administration of cellular therapy productsLaura C Gatzos, Susan Barbetti, Suzanne Bas-Davis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Julie Aldridge, et al.
Pageof 32

Showing results (101-110 of 315) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|October 4, 2007
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysisCatherine J Wu, Mark Gladwin, John Tisdale, et al.
The New England Journal of Medicine|April 29, 2026
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host DiseaseKaramjeet S Sandhu, Jessica Cheng, Patrick W Mellors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Leukemia & Lymphoma|March 5, 2003
Quantitative monitoring of BCR/ABL transcript during STI-571 therapyCatherine J Wu, Donna Neuberg, Antoinette Chillemi, et al.
Transfusion|February 14, 2004
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapyAbba C Zubair, David Zahrieh, Heather Daley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopesYishai Ofran, Haesook T Kim, Vladimir Brusic, et al.
Respiratory Medicine|December 1, 2012
Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantationLee Gazourian, Anna Maria F Coronata, Angela J Rogers, et al.
Journal of Oncology Practice|January 2, 2013
Development and implementation of a computerized system for collection, processing, and administration of cellular therapy productsLaura C Gatzos, Susan Barbetti, Suzanne Bas-Davis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Julie Aldridge, et al.
Pageof 32